RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (23)
Experimental datasets on the characterization of graphene oxide and its reproductive and developmental effects on Japanese medaka (Oryzias latipes) fish.
Inflammation, microbiome and colorectal cancer disparity in African-Americans: Are there bugs in the genetics?
A Comparison of Haitian and American Bachelor of Science in Nursing Students' Perceptions of Cigarette Smoking and E-Cigarette Use.
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
The impairment of insulin signaling in Alzheimer's disease.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Foster, David A.
One or more keywords matched the following items that are connected to
Foster, David A.
Item Type
Name
Academic Article
Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.
Academic Article
Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).
Academic Article
Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway.
Academic Article
Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells.
Academic Article
High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.
Academic Article
Inhibition of fatty acid synthase induces pro-survival Akt and ERK signaling in K-Ras-driven cancer cells.
Academic Article
Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin.
Academic Article
Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.
Academic Article
Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells.
Academic Article
Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid.
Academic Article
Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by glutamine.
Academic Article
Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids.
Academic Article
Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells.
Academic Article
Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6.
Academic Article
Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling.
Academic Article
Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.
Academic Article
Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
Academic Article
Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells.
Academic Article
The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2.
Academic Article
Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells.
Academic Article
Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2.
Academic Article
Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.
Academic Article
Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras.
Concept
Proto-Oncogene Proteins
Concept
Genes, ras
Concept
Proto-Oncogene Proteins c-myc
Concept
Proto-Oncogene Proteins p21(ras)
Concept
ras Proteins
Concept
Proto-Oncogene Proteins c-raf
Concept
Cyclin-Dependent Kinase Inhibitor p21
Concept
Proto-Oncogene Proteins c-akt
Concept
Proto-Oncogene Proteins c-mdm2
Academic Article
Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells.
Search Criteria
Proto Oncogene Proteins
p21
ras